Robert Thomas Dechant, Chief Executive Officer and Director of IBEX Ltd, filed a Form 4 on November 10, 2026, disclosing the sale of 5,000 common shares on November 9, 2026, pursuant to a 10b5-1 plan.

Key Highlights

  • Shares sold: 5,000 common shares of IBEX Ltd were disposed of on November 9, 2026.
  • Weighted average price: The reported sale price was $50.0062 per share, reflecting a weighted average across multiple trades ranging from $50.00 to $50.14.
  • Remaining ownership: Following the transaction, Dechant directly beneficially owns 297,448 common shares.
  • 10b5-1 plan: The sales were made pursuant to a 10b5-1 plan dated November 18, 2025, according to the filing.
  • Transaction code: The transaction is coded "S" (sale) under Instruction 8, with direct ownership form.

Dechant's November 2026 Share Sale Under Prearranged Plan

According to the Form 4 filed with the SEC on November 10, 2026, Robert Thomas Dechant, who serves as both Chief Executive Officer and Director of IBEX Ltd (NASDAQ:IBEX), disposed of 5,000 common shares on November 9, 2026. The filing identifies the transaction code as "S," indicating a sale. The transaction was executed in multiple trades at prices ranging from $50.00 to $50.14 per share, with the weighted average sales price reported as $50.0062.

The filing states that the sales were made pursuant to the reporting person's 10b5-1 plan dated November 18, 2025. The filing further notes that Dechant "undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price." Following the reported transaction, Dechant directly beneficially owns 297,448 common shares. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Lisa Lenstrohm as Attorney-in-Fact on November 10, 2026. The filing was submitted by one reporting person. The box on the form indicating that the transaction was made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c) was checked.

What Was Disclosed

IBEX Ltd CEO Robert Thomas Dechant reported the sale of 5,000 common shares on November 9, 2026, at a weighted average price of $50.0062, under a prearranged 10b5-1 plan. His direct beneficial ownership following the transaction stands at 297,448 common shares.